Presentation Type
Poster
Start Date
5-8-2013 11:00 AM
Subjects
Cellular immunity, Immune response, Cancer vaccines -- Development, Biomedical materials, Vaccines -- Biotechnology
Abstract
Aluminum oxide nanoparticles (Al2O3 NPs) have been shown to increase the efficiency of cell-mediated immune response. Specifically, CD8 and CD4 immune response is required for T cell activation by dendritic cells. These nanoparticles, when functionalized with peptides and other molecules, can be used as vaccine in cancer treatment. In this study, Al2O3 NPs were attached to E6/E7 proteins. HPV-induced cervical cancer expresses E6/E7 antigens. E6/E7 proteins were attached using surface modification of the Al2O3 NPs; different types of molecules were tested to see which adhered the highest amount of protein and produced the strongest cell response. Protein measurements were done using bicinchoninic acid assay (BCA assay) and spectrophotometry. CD8 and CD4 immune response was measured in vivo using flow cytometry. In vitro measurements of immune response were done using B3Z T cells. When coated on the nanoparticles and conjugated with E6E7 protein, the polymer polyethylenimine (PEI) proved to be most effective at strengthening the immune response in vaccinated mice. The NPs were characterized using transmission electron microscopy (TEM) and energy dispersive x-ray spectroscopy (EDX). Our findings in this study demonstrate the growing importance of applied physics in the fields of medicine and biology. Fabrication and characterization of nano-materials are important for improving vaccine delivery and ensuring effectiveness.
Rights
© Copyright the author(s)
IN COPYRIGHT:
http://rightsstatements.org/vocab/InC/1.0/
This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).
DISCLAIMER:
The purpose of this statement is to help the public understand how this Item may be used. When there is a (non-standard) License or contract that governs re-use of the associated Item, this statement only summarizes the effects of some of its terms. It is not a License, and should not be used to license your Work. To license your own Work, use a License offered at https://creativecommons.org/
Persistent Identifier
http://archives.pdx.edu/ds/psu/9441
Included in
Polyethylenimine-Enhanced Alumina Nanoscale Adjuvant for Cancer Vaccine
Aluminum oxide nanoparticles (Al2O3 NPs) have been shown to increase the efficiency of cell-mediated immune response. Specifically, CD8 and CD4 immune response is required for T cell activation by dendritic cells. These nanoparticles, when functionalized with peptides and other molecules, can be used as vaccine in cancer treatment. In this study, Al2O3 NPs were attached to E6/E7 proteins. HPV-induced cervical cancer expresses E6/E7 antigens. E6/E7 proteins were attached using surface modification of the Al2O3 NPs; different types of molecules were tested to see which adhered the highest amount of protein and produced the strongest cell response. Protein measurements were done using bicinchoninic acid assay (BCA assay) and spectrophotometry. CD8 and CD4 immune response was measured in vivo using flow cytometry. In vitro measurements of immune response were done using B3Z T cells. When coated on the nanoparticles and conjugated with E6E7 protein, the polymer polyethylenimine (PEI) proved to be most effective at strengthening the immune response in vaccinated mice. The NPs were characterized using transmission electron microscopy (TEM) and energy dispersive x-ray spectroscopy (EDX). Our findings in this study demonstrate the growing importance of applied physics in the fields of medicine and biology. Fabrication and characterization of nano-materials are important for improving vaccine delivery and ensuring effectiveness.